Replies to post #140906 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

based on Xena's post 30mg looks good, which I presume is a mouse scaled human equivalent.

We really do not have any concrete data to suggest that 30mg was not well tolerated in frail old AD patients.

I still have an enquiry out with IR and Clayton from Trout Group, repeated today, just see if we can clear up the dosing questions relating to Part B.

[LakeshoreLeo1953]

Without seeing the IND is anyone here prepared to
assert EVEN what end points are sought as part of
the application?

Just a question.....